Mugford C A, Carfagna M A, Kedderis G L
Chemical Industry Institute of Toxicology, Research Triangle Park, North Carolina 27709-2137, USA.
Toxicol Appl Pharmacol. 1997 May;144(1):1-11. doi: 10.1006/taap.1997.8121.
Furan is a potent rodent hepatotoxicant and carcinogen. The present study was done to examine the effects of furan on hepatic energy metabolism both in vivo and in vitro in male F-344 rats. Furan produced concentration- and incubation time-dependent irreversible reductions in ATP in freshly isolated F-344 rat hepatocytes. Furan-mediated depletion of ATP occurred prior to cell death and was prevented by including 1-phenylimidazole, a cytochrome P450 inhibitor, in the suspensions. Male F-344 rats were treated with furan (0-30 mg/kg, po) and killed 24 hr later to prepare hepatic mitochondria. Furan produced dose-dependent increases in state 4 respiration and ATPase activity. Both of these changes were prevented by 1-phenylimidazole cotreatment. In a separate series of experiments, mitochondria were prepared from isolated rat hepatocytes following incubation with furan (2-100 microM) for 1-4 hr. Furan produced incubation time- and concentration-dependent increases in state 4 respiration and ATPase activity. Furan-mediated mitochondrial changes were prevented by adding 1-phenylimidazole to the hepatocyte suspensions. These results indicate that the ene-dialdehyde metabolite of furan uncouples hepatic oxidative phosphorylation in vivo and in vitro. In vitro studies using an isolated hepatocyte suspension/culture system demonstrated that the concentration response for furan-mediated mitochondrial changes in suspension corresponded with the concentration responses for cell death after 24 hr. Including 1-phenylimidazole or oligomycin plus fructose in hepatocyte suspensions prevented furan-induced cell death after 24 hr in culture. The results of this study indicate that furan-induced uncoupling of oxidative phosphorylation is an early, critical event in cytolethality both in vivo and in vitro.
呋喃是一种强效的啮齿动物肝毒素和致癌物。本研究旨在考察呋喃对雄性F-344大鼠体内和体外肝脏能量代谢的影响。呋喃对新鲜分离的F-344大鼠肝细胞中的ATP产生浓度和孵育时间依赖性的不可逆降低。呋喃介导的ATP消耗发生在细胞死亡之前,并且通过在悬浮液中加入细胞色素P450抑制剂1-苯基咪唑可以防止。雄性F-344大鼠用呋喃(0 - 30 mg/kg,口服)处理,24小时后处死以制备肝脏线粒体。呋喃使状态4呼吸和ATP酶活性呈剂量依赖性增加。这两种变化都可通过与1-苯基咪唑共同处理来防止。在另一系列实验中,用呋喃(2 - 100 microM)孵育1 - 4小时后从分离的大鼠肝细胞制备线粒体。呋喃使状态4呼吸和ATP酶活性呈孵育时间和浓度依赖性增加。通过向肝细胞悬浮液中加入1-苯基咪唑可防止呋喃介导的线粒体变化。这些结果表明,呋喃的烯二醛代谢产物在体内和体外均可使肝脏氧化磷酸化解偶联。使用分离的肝细胞悬浮液/培养系统的体外研究表明,呋喃介导的悬浮液中线粒体变化的浓度反应与24小时后细胞死亡的浓度反应相对应。在肝细胞悬浮液中加入1-苯基咪唑或寡霉素加果糖可防止培养24小时后呋喃诱导的细胞死亡。本研究结果表明,呋喃诱导的氧化磷酸化解偶联是体内和体外细胞致死性的早期关键事件。